Is aerosol delivery by high‐flow nasal cannula in children an effective alternative to face mask aerosol nebulization?

2019 ◽  
Vol 54 (12) ◽  
pp. 1873-1874 ◽  
Author(s):  
Sajith Kesavan ◽  
Israel Amirav
2021 ◽  
Vol 67 (1) ◽  
pp. 149-150
Author(s):  
Jessica L Saunders ◽  
Michael D Davis

2017 ◽  
Vol 62 (9) ◽  
pp. 1186-1192 ◽  
Author(s):  
Patricia A Dailey ◽  
Robert Harwood ◽  
Kyle Walsh ◽  
James B Fink ◽  
Tina Thayer ◽  
...  

JMS SKIMS ◽  
2020 ◽  
Vol 23 (3) ◽  
Author(s):  
Tajamul Hussain Shah ◽  
Suhail Mantoo ◽  
Rafi Ahmad Jan

High Flow Nasal Cannula Oxygenation The current pandemic of COVID-19 caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested the healthcare infrastructure throughout the globe at all possible levels. Early reports suggest about 20% of patients infected with SARS-CoV-2 require hospitalization and 5-8% require admission to intensive care unit (ICU) due to severe disease.Supplementation of oxygen provided by various conventional oxygen therapy (COT) devices (like nasal prongs, face mask, venture mask or non-rebreather mask) may not be sufficient in cases of worsening respiratory failure. One form of escalating respiratory support in such patients is a high flow nasal oxygenation device. High flow nasal cannula oxygenation (HFNC) is a form of non invasive respiratory support. It acts as a bridge between low flow devices and non invasive ventilation and may reduce the need for intubation.


2019 ◽  
Vol 64 (4) ◽  
pp. 453-461 ◽  
Author(s):  
Yasmin M Madney ◽  
Maha Fathy ◽  
Ahmed A Elberry ◽  
Hoda Rabea ◽  
Mohamed EA Abdelrahim

2011 ◽  
Vol 46 (8) ◽  
pp. 795-801 ◽  
Author(s):  
Arzu Ari ◽  
Robert Harwood ◽  
Meryl Sheard ◽  
Patricia Dailey ◽  
James B. Fink

2019 ◽  
Vol 20 (-1) ◽  
pp. 53-53
Author(s):  
Aykut Eksi ◽  
◽  
Gokcen Kartal Ozturk ◽  
Caner Turan ◽  
Figen Gulen ◽  
...  

2020 ◽  
pp. 00422-2020 ◽  
Author(s):  
Yasmin M. Madney ◽  
Nabila Ibrahim Laz ◽  
Ahmed A. Elberry ◽  
Hoda Rabea ◽  
Mohamed E.A. Abdelrahim

There is a lack of information about the influence of patient interfaces like facemask or mouthpiece on the effective dose of aerosolized drugs while using high flow therapy in a clinical setting. These interfaces can improve pulmonary drug delivery over nasal cannula but patient preference and comfort should also be considered.The present work was to determine the effect of three different interfaces (nasal cannula, valved face mask, and mouthpiece) when combined with titrated oxygen flow on aerosol delivery in chronic obstructive pulmonary disease (COPD) patients hospitalised due to acute exacerbation.The variations between these interfaces were addressed in terms of change in lung function measurements pre-and post-inhalation, the delivered salbutamol dose, and patient tolerance to each interface.High flow nasal cannula was the most comfortable interface used. However, its pulmonary drug delivery was significantly lower than both the valved face mask and mouthpiece (p<0.05). Although drug delivery was different with the three tested interfaces, the lung function improvements were similar.


Sign in / Sign up

Export Citation Format

Share Document